Leptin in association with common variants of MC3R mediates hypertension

American Journal of Hypertension

Volumn 27, Issue 7, 2014, Pages 973-981

  Alsmadi, Osama ^a   Melhem, Motasem ^a   Hebbar, Prashantha ^a   Thareja, Gaurav ^a   John, Sumi E ^a   Alkayal, Fadi ^a   Behbehani, Kazem ^a   Thanaraj, Thangavel Alphonse ^a  

^a DASMAN DIABETES INSTITUTE   (Kuwait)

Author keywords

blood pressure; hypertension; leptin; MC3R; MC4R; melanocortin

Indexed keywords

LEPTIN; MELANOCORTIN 3 RECEPTOR; MC3R PROTEIN, HUMAN; MC4R PROTEIN, HUMAN; MELANOCORTIN 4 RECEPTOR; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; ASIAN CONTINENTAL ANCESTRY GROUP; BLACK PERSON; BLOOD; BLOOD PRESSURE; CAUCASIAN; GENETICS; KUWAIT; MIDDLE AGED; AGE DISTRIBUTION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; DISEASE ASSOCIATION; EUROPEAN; GENE SEQUENCE; GENOTYPE; KUWAITI; OBESITY; SEX DIFFERENCE; SYMPATHETIC NERVE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAPLOTYPES; HUMANS; HYPERTENSION; KUWAIT; LEPTIN; MALE; MIDDLE AGED; MUTATION, MISSENSE; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 84902522595     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt285     Document Type: Article

References (26)

1. Gantz I, Fong TM. The melanocortin system. Am J Physiol Endocrinol Metab 2003; 284:E468-474.
2. Wilson BD, Bagnol D, Kaelin CB, Ollmann MM, Gantz I, Watson SJ, Barsh GS. Physiological and anatomical circuitry between Agouti-related protein and leptin signaling. Endocrinology 1999; 140:2387-2397.
3. Zhang Y, Wu X, He Y, Kastin AJ, Hsuchou H, Rosenblum CI, Pan W. Melanocortin potentiates leptin-induced STAT3 signaling via MAPK pathway. J Neurochem 2009; 110:390-399.
4. Yuan CS, Attele AS, Zhang L, Lynch JP, Xie JT, Shi ZQ. Leptin reduces body weight gain in neonatal rats. Pediatr Res 2000; 48:380-383.
5. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1:1155-1161.
6. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999; 33:542-547.
7. Simonds SE, Cowley MA. Hypertension in obesity: Is leptin the culprit? Trends Neurosci 2013; 36:121-132.
8. Li P, Cui BP, Zhang LL, Sun HJ, Liu TY, Zhu GQ. Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure. Exp Physiol 2013; 98:435-443.
9. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105:1243-1252.
10. Ni XP, Pearce D, Butler AA, Cone RD, Humphreys MH. Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J Clin Invest 2003; 111:1251-1258.
11. Ni XP, Humphreys MH. Abnormal glucose metabolism in hypertensive mice with genetically interrupted gamma-melanocyte stimulating hormone signaling fed a high-sodium diet. Am J Hypertens 2008; 21:1284-1287.
12. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O'Rahilly S, Farooqi IS. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360:44-52.
13. Yako YY, Fanampe BL, Hassan SM, Erasmus RT, van der Merwe L, Matsha TE. Negative association of MC3R variants with weight and blood pressure in Cape Town pupils aged 11-16 years. S Afr Med J 2011; 101:417-420.
14. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36:936-942.
15. Al-Herz W, Alsmadi O, Melhem M, Recher M, Frugoni F, Notarangelo LD. Major histocompatibility complex class II deficiency in Kuwait: Clinical manifestations, immunological findings and molecular profile. J Clin Immunol 2013; 33:513-519.
16. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-4680.
17. Ahmad A, Ahmad R, Toma E, Morisset R, Menezes J. Impaired induction of IL-15 in response to herpes simplex virus type 1 infection in peripheral blood mononuclear cells of HIV-infected patients. AIDS 2000; 14:744-746.
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
19. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010; 26:2069-2070.
20. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003; 31:3812-3814.
21. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7:248-249.
22. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491:56-65.
23. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000; 26:97-102.
24. Mencarelli M, Walker GE, Maestrini S, Alberti L, Verti B, Brunani A, Petroni ML, Tagliaferri M, Liuzzi A, Di Blasio AM. Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur J Hum Genet 2008; 16:581-586.
25. Feng N, Young SF, Aguilera G, Puricelli E, Adler-Wailes DC, Sebring NG, Yanovski JA. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 2005; 54:2663-2667.
26. Channanath AM, Farran B, Behbehani K, Thanaraj TA. State of diabetes, hypertension, and comorbidity in Kuwait: Showcasing the trends as seen in native versus expatriate populations. Diabetes Care 2013; 36:e75.